Skip to main content

Recommended

Services

    PI Leaflets

      Pages

        No results found.

        Pathology tests database

        Back to Clinical Biochemistry

        HVA and HMMA/VMA

        Clinical Biochemistry

        Sample and container requirements

        Plain Spot Urine

        Minimum volume required

        1 mL urine

        Special requirements

        Adjust pH to 3.0 - 3.5 on receipt in the laboratory.

        Patient preparation

        None

        Sample viability

        Turnaround time

        2 days

        Reference range

        HVA: Infant: 4 – 25 µmol/mmol creatinine 1 – 5 years: 2 – 15 µmol/mmol creatinine >5 years: 2 – 13 µmol/mmol creatinine HMMA/VMA: Infant: 2 – 12 µmol/mmol creatinine 1 year – 5 years: 2 – 9 µmol/mmol creatinine > 5 years: 1 – 7 µmol/mmol creatinine

        Clinical guidance

        Neuroblastoma is a neoplastic disease of infants and early childhood and is the third most common malignant cancer tumours in paediatric patients. Approximately 80% are found in children under 5 years of age. Elevated values of homovanillic acid (HVA, a metabolite of dopamine) and HMMA/VMA (a metabolite of metadrenalines), may be suggestive of the presence of neuroblastoma. HVA and HMMA/VMA can be used for the diagnosis and follow up treatment of neuroblastoma.

        Notes

        Please contact the Duty Biochemist on 0121 424 1392 (or bleep 2506) prior to sending samples for this test.

        Images to go here

        This information was last updated on 19 August 2026